新锐医药(06108)发布中期业绩,净亏损745.4万港元,同比扩大82.3%

智通财经
Aug 27

智通财经APP讯,新锐医药(06108)发布2025年中期业绩,收益4470.1万港元,同比增长167.4%;净亏损745.4万港元,同比扩大82.3%;每股基本亏损0.45港仙。

期内收益增加乃由于集团自2024年下半年起于中国推出新产品及部分被该产品于期内的需求下跌抵销,其原因为中国内地多个地区进一步加强采用抗菌药物分级分类管理政策,带来持续不利影响。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10